Risk factor
Very poor trading liquidity
Profitability factor
Greatly undervalued vs peers
About
Vivo Bio Tech Ltd. specializes in delivering comprehensive services for pharmaceutical research and development. The company's diverse offerings encompass both in-vivo and in-vitro toxicology assessments, in-depth pharmacological investigations, pharmacokinetic and toxicokinetic analyses, genotoxicity screening, and a variety of analytical services. The firm conducts its operations through distinct Bio Agriculture and Industrial segments. Founded by Vish Kompella on February 12, 1987, the enterprise maintains its primary headquarters in Hyderabad, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. Specifically, the stock is undervalued on EV/EBITDA.